Merck chalks up another Vioxx victory

A Florida jury ruled for Merck in yet another Vioxx case, bringing the drug maker's record to 11-5 in trials related to the drug. The newest case involved a former professional soccer player, Refik Kozic, who had a heart attack in 2001 at the age of 50. The jury decided that Vioxx didn't cause Kozic's heart attack.

Merck, of course, pulled Vioxx from the market in 2004 because of increased risk of heart attack and stroke. Some 45,000 product liability cases are pending.

- check out Merck's release

Related Articles:
NY double-teams Merck in Vioxx lawsuit. Report
Merck takes tough stance on Vioxx. Report
Vioxx defense dealt a blow by new study results. Report
Up to 100,000 Vioxx claims expected. Report
Merck faces long road in Vioxx battle. Report

Launch Readiness

Optimize cross-functional collaboration and engage with key stakeholders for the successful launch of a product

Join the Launch Readiness for Medical Affairs & Communications Teams Summit to learn best practices in taking a structured approach to enhance medical affairs activities surrounding a launch and increase knowledge and communication with thought leaders.